Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-20-006428
Filing Date
2020-06-29
Accepted
2020-06-29 06:13:55
Documents
22

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 66734
2 filename2.htm EX-10.1 649299
3 filename3.htm EX-10.2 34661
4 filename4.htm EX-10.3 40191
5 filename5.htm EX-10.4 57539
6 filename6.htm EX-10.5 643893
7 filename7.htm EX-10.6 103016
8 filename8.htm EX-10.7 178740
9 filename9.htm EX-10.8 179468
10 filename10.htm EX-10.9 10723
11 filename11.htm EX-10.10 10120
12 filename12.htm EX-10.11 195138
13 filename13.htm EX-10.12 59835
14 filename14.htm EX-10.13 17793
15 GRAPHIC g857852g13w79.jpg GRAPHIC 10522
16 GRAPHIC g857852g65h89.jpg GRAPHIC 174655
17 GRAPHIC g857852g65o53.jpg GRAPHIC 798
18 GRAPHIC g857852gra036.jpg GRAPHIC 18425
19 GRAPHIC g857852gra039a.jpg GRAPHIC 12838
20 GRAPHIC g857852gra039b.jpg GRAPHIC 11570
21 GRAPHIC g857852gra039c.jpg GRAPHIC 13845
22 GRAPHIC g857852sp01a.jpg GRAPHIC 10007
  Complete submission text file 0000950123-20-006428.txt   2575941
Mailing Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2FX
Business Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2FX 44 (0)1438 906870
Freeline Therapeutics Holdings Ltd (Filer) CIK: 0001810031 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-03158 | Film No.: 20995857
SIC: 2836 Biological Products, (No Diagnostic Substances)